Market Spotlight
Danaher Stock Analysis: What the Latest DHR Results Mean for Investors
Danaher beat on Q3 adjusted EPS at $2.11 and raised full-year guidance, but core growth was 3.0% against 5.5% excluding the respiratory testing drag.
Jack Green·22 Oct 2026